Latest Piperazines Stories
SUNNYVALE, Calif., June 9, 2014 /PRNewswire/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today announced that the U.S.
Two New Therapies Will Match Progression-Free Survival Improvements Required By Surveyed U.S.
The DrugNews Center is the largest source for prescription drug and medical device warnings, research and legal news.
On June 3, the FDA notified consumers not to purchase or use Liu Bian Li, Eyeful, Dick’s Hard Up, 3 Hard Knights, Full Throttle On Demand, and GoldReallas because they were found to contain
High Cost and High Expectations for Clinical Benefits are Major Market Access Hurdles Facing New CML Therapies, According to Findings from Decision Resources Group BURLINGTON, Mass., June 2,
Erectile dysfunction is a very common problem and affects tens of millions men over 40 years old in the United States.
Companies anticipate providing over-the-counter (OTC) product to treat erectile dysfunction after expiration of certain patents PARIS and INDIANAPOLIS, May 28, 2014 /PRNewswire/ -- Sanofi (EURONEXT:
Robust Value Dossiers and Smart Uptake Strategies are Vital to Secure Optimal Market Access in Europe, According to Findings from Decision Resources Group BURLINGTON, Mass., May 27, 2014 /PRNewswire/
Ashley Brittain Landers of Schlichter, Bogard & Denton, LLP reports that a new study published in JAMA Internal Medicine in April 2014 suggests that there may be a potential link between sildenafil
A Group of 50 Adverse Drug Reaction Victims Rally in Washington, DC Before Meeting with Members of Congress; Thousands Connect Via Online Support Groups Emerging Worldwide WASHINGTON,
- A trick or prank.